Product Description
Overall, the global phacoemulsification console market was valued at approximately $175 million in 2022. This is expected to increase over the forecast period at a CAGR of 2.9% to reach approximately $213 million.
Throughout this medical market research, we analyzed over 10 phacoemulsification console companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global phacoemulsification console market includes a complete analysis of phacoemulsification consoles.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Phacoemulsification Console Market Insights
Leading companies that also hold sway over the intraocular lens (IOL) market exert a dominant presence in the phacoemulsification console industry. Their practice of bundling phacoemulsification consoles with IOLs and disposable supplies creates a formidable barrier for independent manufacturers seeking entry into this market.
Global Phacoemulsification Console Market Share Insights
In the global phacoemulsification console market of 2022, Alcon held the top position as the primary contender. Alcon’s INFINITI® Vision System was its flagship product that enabled the company to compete effectively.
Securing the second-place position in the global phacoemulsification console market in 2022 was J&J Vision Care. Their prominent offering in this market was the WHITESTAR Signature® Pro phacoemulsification system.
As of 2022, Bausch & Lomb ranked as the third-leading competitor in the global phacoemulsification console market. The Stellaris™ Vision Enhancement System, their key product, distinguished itself by providing both flow and vacuum control through a single, innovative pump device.
Market Segmentation Summary
- Global Phacoemulsification Console Market
Global Phacoemulsification Console Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2022 |
Forecast | 2023-2039 |
Historical Data | 2019-2022 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.